Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra vs IVIG Retreatment in IVIG-Resistant Kawasaki Disease
NCT04656184Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2023
- Primary completion
- Mar 2027
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of anakinra in Kawasaki disease (KD), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2023; status: recruiting.
02
Drugs
anakinra
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT04656184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04656184.